#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pericarditis Autoimmune hepatitis Spina bifida Small intestine leiomyosarcoma Chondrosarcoma metastatic Central nervous system neoplasm Cardiac arrest Hypomagnesaemia Plasma cell myeloma recurrent Trigeminal neuralgia Hepatitis D Follicular lymphoma Advanced systemic mastocytosis Cutaneous T-cell lymphoma refractory Cutaneous T-cell lymphoma stage I More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX Haemophilia A with anti factor VIII – Trials in Disease Angiosarcoma recurrent MELAS syndrome – Trials in Disease Prolymphocytic leukaemia – Trials in Disease Acute respiratory distress syndrome – Treatment Splenic marginal zone lymphoma – Life with Disease Lysosomal storage disorder – Treatment Vascular malformation Ewing’s sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Balstilimab Benzylpenicillin TRIMIPRAMINE MALEATE Triamcinolone Hexacetonide SP16 Gsk4011499 SONLICROMANOL HYDROCHLORIDE Mva-209-Fsp-B3 SODIUM SELENITE PENTAHYDRATE Defactinib Desoximetasone S227928 Resiniferatoxin Dabigatran SILYMARIN IHMA-2121908-1 Kyv-101 Quc398 Diclofenac Diethylamine Rotigotine More therapies…

    Learn about Your Condition

    HIV infection Cardiac failure chronic Osteoarthritis Breast cancer stage III Skin angiosarcoma Renal cell carcinoma stage IV Deep vein thrombosis Vulvovaginal pain Enteritis Cerebral palsy Pancreatic carcinoma Anal cancer recurrent Adenosquamous cell lung cancer Mantle cell lymphoma recurrent Arthritis infective More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centrum Medyczne LukaMed Joanna Łuka

Centrum Medyczne LukaMed Joanna Łuka

Ul. Mickiewicza 39, Chojnice, 89-600, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Effects of Diclofenac Diethylamine Gel on Physical Activity and Quality of Life in Patients with Mild Knee Osteoarthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Diclofenac Diethylamine
    Poland

  • Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Salbutamol
    • Beclometasone Dipropionate Anhydrous
    • Glycopyrronium Bromide
    Bulgaria Czechia Germany Greece Hungary Italy +5

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Jnj-77242113
    • Azathioprine
    • Mercaptopurine
    Belgium Czechia France Germany Hungary Italy +3

  • Study on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Bulgaria Czechia Hungary Latvia Poland Romania +1

  • Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Croatia Czechia Denmark +10
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!